| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5623775 | Alzheimer's & Dementia | 2016 | 10 Pages |
Abstract
Low-CSF mtDNA is not a consequence of brain damage and allows the differential diagnosis of AD from sCJD and other dementias. These results support the hypothesis that mtDNA in CSF is a pathophysiological biomarker of AD.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Petar Podlesniy, Franc Llorens, Ewa Golanska, Beata Sikorska, Pawel Liberski, Inga Zerr, Ramon Trullas,